Hangzhou Minsheng Binjiang Pharma (HMBP) is wholly-owned by Minsheng Pharma (founded in 1926). It obtained US FDA approval in 2011 & 2014 for solid dosage forms. The plant owns one blister line and one bottle line and focuses on generics for regulated markets.
Based on APIs and focused on preparations, the company produces and develops products of high-tech. It produces active pharmaceutical ingredients and four categories of drug formulations . All of the products and facilities have GMP certificates issued by SDA(State Drug Administration).
North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Categories affiliated with Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation